Cost Effectiveness Analysis [ocac]
Thiazolidinediones [orch, phsu]
Uncontrolled [qlco]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Receive [qlco]
Sulfonylureas [orch, phsu]
Metformin [orch, phsu]
Thailand [geoa]
Objective [inpr]
national [inpr]
essential drug [phsu]
Committee [grup]
Thailand [geoa]
Suggest [idcn]
Thiazolidinediones [orch, phsu]
included [ftcn]
Hospital Formulary [inpr]
Little NOS [cgab, dsyn]
Cost Effectiveness [qnco]
Values [qlco]
Study [mnob]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
pioglitazone 45 MG [clnd]
Compared [acty]
rosiglitazone 8 MG [clnd]
Uncontrolled [qlco]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Receive [qlco]
Sulfonylureas [orch, phsu]
Metformin [orch, phsu]
Thailand [geoa]
Methods [inpr]
Diabetes [dsyn]
Center [spco]
outcome research [fndg]
Study [mnob]
baseline [bodm]
Characteristics [qlco]
Patients [podg]
Based [ftcn]
Thai [popg]
Diabetes [dsyn]
Registry [inpr]
Project [cnce]
Costs [qnco]
Diabetes [dsyn]
Calculated [ftcn]
Hospital [hcro, mnob]
Non-specific [qlco]
Mortality rate [qnco]
Transition [comd]
Probabilities [qnco]
Renal Replacement Therapy [topp]
Obtained [ftcn]
Thai [popg]
sources [fndg]
Effectiveness [qlco]
Meta-Analysis [inpr]
Based [ftcn]
Government hospital [hcro, mnob]
Policy Maker [prog]
Cost [qnco]
discount [inpr]
base [inch]
Incremental [qnco]
Cost [qnco]
Year, Quality-Adjusted Life [tmco]
Gain [qnco]
Series [qnco]
Sensitive [ftcn]
Performed [ftcn]
base [inch]
pioglitazone [orch, phsu]
Group [idcn]
Costs [qnco]
Incremental [qnco]
Cost [qnco]
Year, Quality-Adjusted Life [tmco]
Gain [qnco]
Baht [qnco]
acceptability [qlco]
Curve [spco]
Probability [qnco]
pioglitazone [orch, phsu]
Cost Effectiveness [qnco]
Willing [fndg]
pay [qnco]
one time [inpr]
Thai [popg]
Gross Domestic Product [qnco]
Caput [blor]
GDP [bacs, nnon]
Caput [blor]
pioglitazone [orch, phsu]
Decrease [qlco]
Sensitive [ftcn]
Final [tmco]
Conclusions [idcn]
findings [ftcn]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Blood Glucose [carb]
Combination [qlco]
Sulfonylurea [orch, phsu]
Metformin [orch, phsu]
pioglitazone [orch, phsu]
4s [bpoc]
mg% [qnco]
Fall [fndg]
Cost Effectiveness [qnco]
Range [qnco]
Recommended [idcn]
World Health Organization [hcro]
times [tmco]
GDP [bacs, nnon]
Caput [blor]
Average [qnco]
Compared [acty]
rosiglitazone 8 MG [clnd]
Based [ftcn]
Sensitivity [qnco]
Probability [qnco]
Cost Effectiveness [qnco]
Hospital [hcro, mnob]
findings [ftcn]
Part [spco]
Information [idcn]
Decision Making [menp]
Process [bpoc]
